BioCentury
ARTICLE | Company News

Chrysalis International, Phoenix International Life Sciences Inc. deal

November 23, 1998 8:00 AM UTC

PHX, a CRO, will acquire all outstanding shares of CRLS, also a CRO, for $8.3 million in PHX stock. PHX will register its shares on NASDAQ in order to issue the shares. If the listing is not obtained,...